NCT04886297

A Dose-response Study of Dietary Resveratrol on Lipid Metabolism Disorder

Department of Nutrition and Food Hygiene,School of Public Health, Sun Yat-sen University

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 168 (actual)
• Sponsor: Sun Yat-sen University · Academic / Other
• Sex: All
• Age: 35 Years – 70 Years
• Healthy volunteers: Accepted

Summary

In order to study the effect of resveratrol on the improvement of lipid and uric acid metabolism, randomized intervention trials were conducted to compare the effects of resveratrol on the improvement of lipid and uric acid metabolism in different dose groups. To explore the best dose of resveratrol for the prevention and treatment of metabolic diseases provide an important scientific basis.

Detailed description

In order to study the effect of resveratrol on the improvement of lipid and uric acid metabolism, randomized controlled trials were conducted to enrolled 160 patients with dyslipidemia. The subjects were divided into 0 mg / d, 100 mg / d, 300 mg / d, 600 mg/ d four dose groups, intervention for 8 weeks, comparing different doses of resveratrol on lipid and uric acid metabolism. To explore the best dose of resveratrol for the prevention and treatment of metabolic diseases provide an important scientific basis.

Conditions

• Dyslipidemias

Interventions

Type	Name	Description
DRUG	Mega Resveratrol® capsules	Subjects were orally administered Mega Resveratrol® capsules daily for 8 weeks.
DRUG	Mega Resveratrol® Placebo capsules	Mega Resveratrol® Placebo capsules

Timeline

• Start date: 2021-05-01
• Primary completion: 2022-05-30
• Completion: 2022-09-30
• First posted: 2021-05-14
• Last updated: 2022-10-27

Locations

1 site across 1 country: China